6-Methoxy-1H-indanone CAS:13623-25-1
6-Methoxy-1H-indanone has several significant applications, primarily in medicinal chemistry and organic synthesis. In the pharmaceutical field, this compound serves as a valuable intermediate for synthesizing various bioactive molecules. Researchers investigate its derivatives for potential therapeutic effects, including anti-inflammatory, analgesic, and anticancer activities. The methoxy group enhances the compound's solubility and biological availability, making it a candidate for drug development focused on improving pharmacological profiles. Additionally, 6-Methoxy-1H-indanone is utilized as a building block in organic synthesis, allowing chemists to create more complex organic compounds through various reactions. Its reactivity can be harnessed in the preparation of heterocyclic compounds, which are essential in developing new pharmaceuticals and agrochemicals. The compound's ability to undergo electrophilic aromatic substitution makes it suitable for further modifications, expanding the library of potential derivatives for biological testing. In the realm of materials science, 6-Methoxy-1H-indanone may also find application in the synthesis of polymers and other advanced materials. Its unique structure can contribute to attaining specific physical and chemical properties in these materials, enhancing performance in various applications. Moreover, this compound is of interest in flavor and fragrance chemistry due to its aromatic profile, which may allow it to be incorporated into perfumery or flavoring formulations. Overall, the diverse applications of 6-Methoxy-1H-indanone in pharmaceuticals, organic synthesis, materials science, and potentially in the fragrance industry emphasize its significance as a versatile and valuable compound in both research and industrial contexts.
Composition | C10H10O2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 13623-25-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |